Spirair

Founded: 2020 • Age: 6 yrs
Medical devices for nasal septal deviation treatment are developed.
Request Access

About Spirair

Spirair is a company founded in 2020.. Spirair has raised $12.76 million across 1 funding round. Spirair offers products and services including SeptAlign. Spirair operates in a competitive market with competitors including Navage, Arrinex, Chordate, ENTpro and NeilMed, among others.

  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $12.76 M (USD)

    in 1 rounds

  • Latest Funding Round
    $12.76 M (USD), Series B

    Jul 28, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Spirair

Spirair offers a comprehensive portfolio of products and services, including SeptAlign. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Bioabsorbable device for mechanical correction of nasal septal deviations.

Funding Insights of Spirair

Spirair has successfully raised a total of $12.76M through 1 strategic funding round. The most recent funding activity was a Series B round of $12.76 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $12.8M
  • First Round

    (28 Jul 2025)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2025 Amount Series B - Spirair Valuation

investors
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Investments & Acquisitions by Spirair

Investments
Company Name Description Domain Location Founded Year Amount
Bento Cloud
Bionic investment advisor platform
2016
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
GrabKios by Kudo
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Spirair

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Spirair Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Spirair

Spirair operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Navage, Arrinex, Chordate, ENTpro and NeilMed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
Navage
domain founded_year HQ Location
Nasal irrigator that uses suction
Arrinex
domain founded_year HQ Location
Hand-held disposable cryotherapy devices for ENT procedures are developed.
Chordate
domain founded_year HQ Location
Develops and markets CE-marked devices for migraine and rhinitis treatment.
ENTpro
domain founded_year HQ Location
Simple medical devices for nasal cleaning and reduction of snoring
NeilMed
domain founded_year HQ Location
Manufactures nasal irrigation systems for sinus and allergy relief worldwide.
Nasal Medical
domain founded_year HQ Location
Products for comfortable breathing and sleep aids are developed.
Company Name Domain Founded year HQ Location Description
inDrive
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
Bolt
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
Gojek
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
Dunzo
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Spirair

Frequently Asked Questions about Spirair

When was Spirair founded?

Spirair was founded in 2020 and raised its 1st funding round 5 years after it was founded.

Is Spirair a funded company?

Spirair is a funded company, having raised a total of $12.76M across 1 funding round to date. The company's 1st funding round was a Series B of $12.76M, raised on Jul 28, 2025.

What does Spirair do?

Spirair was founded in 2020 as a developer of medical devices focused on nasal septal deviation. Minimally invasive solutions are provided to address nasal obstruction, with applications in ear, nose, and throat conditions as well as sleep disorders. Operations center on innovation within the medical device sector, targeting treatments that support respiratory health without extensive surgical intervention.

Who are the top competitors of Spirair?

Spirair's top competitors include Navage, Arrinex and Nasal Medical.

What products or services does Spirair offer?

Spirair offers SeptAlign.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available